3 completed, 1 enrolling by invitation, 1 recruiting. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Enrolling by invitation 1, Recruiting 1 |
Follow Kybella: new trials by email Literature Review of Kybella trials Research Report on Kybella
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma Ronkyla Plus, Placebo, Kybella - Lipoma, Submental Fullness | Phase 1 | Recruiting | Glonova Pharma Co., Ltd | 56 | 2025-11-14 | 2026-10-02 |
| Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) Kybella - Neurofibromas, Cutaneous, Neurofibromatosis 1 | Phase 1 | Enrolling by invitation | Massachusetts General Hospital | 15 | 2025-04-08 | 2026-04-22 |
| Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas Deoxycholic Acid, Polidocanol, 1064nm Nd:YAG laser - Neurofibromatosis 1 | Phase 1 | Completed | Massachusetts General Hospital | 13 | 2024-03-01 | 2025-11-21 |
| Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas Kybella, Asclera - Neurofibromatosis 1 | Phase 1 | Completed | Massachusetts General Hospital | 20 | 2022-12-06 | 2025-02-21 |
| Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas Kybella, 1064nm laser, 755nm Alexandrite Laser - Cutaneous Neurofibroma | Phase 1 | Completed | Massachusetts General Hospital | 34 | 2021-06-02 | 2025-02-21 |
Neurofibromatosis 1 (4) · Lipoma (1) · Neurofibroma (1)
Massachusetts General Hospital (4) · Glonova Pharma Co., Ltd (1)
United States (4) · Taiwan (1)
Richard R Anderson, MD (3) · R. Rox Anderson, MD (1) · Yu-Hsiu Yen, MD (1)